Thomas K Equels Aim Immuno Tech Inc. (AIM) insider trading activity

AIM Quotes by TradingView

Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 38,885 shares of AIM, which is worth approximately $353,853. The most recent transaction as insider was on Jun 13, 2025, when has been sold 107 shares (Common Stock) at a price of $7.7 per share, resulting in proceeds of $823. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.9K
98.99% 3M change
95.0% 12M change
Total Value Held $353,853

Thomas K Equels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2025
BUY
Open market or private purchase
$823 $7.7 p/Share
107 Added 0.27%
38,885 Common Stock
Jun 12 2025
BUY
Open market or private purchase
$896 $8.7 p/Share
103 Added 0.27%
38,675 Common Stock
Apr 11 2025
BUY
Open market or private purchase
$59,055 $0.03 p/Share
1,968,504 Added 33.73%
3,867,533 Common Stock
Apr 04 2025
BUY
Open market or private purchase
$2,460 $0.06 p/Share
41,000 Added 2.11%
1,899,029 Common Stock
Mar 05 2025
BUY
Open market or private purchase
$6,500 $0.13 p/Share
50,000 Added 2.62%
1,858,029 Common Stock
Mar 04 2025
BUY
Open market or private purchase
$5,280 $0.12 p/Share
44,000 Added 2.38%
1,808,029 Common Stock
Mar 04 2025
BUY
Open market or private purchase
$10,000 $0.12 p/Share
83,334 Added 4.51%
1,764,029 Common Stock
Dec 18 2024
BUY
Open market or private purchase
$4,772 $0.21 p/Share
22,727 Added 1.33%
1,680,695 Common Stock
Nov 21 2024
BUY
Open market or private purchase
$4,200 $0.21 p/Share
20,000 Added 1.19%
1,657,968 Common Stock
Nov 20 2024
BUY
Open market or private purchase
$17,000 $0.2 p/Share
85,000 Added 4.93%
1,637,968 Common Stock
Nov 20 2024
BUY
Open market or private purchase
$10,819 $0.18 p/Share
60,110 Added 3.73%
1,552,968 Common Stock
Sep 16 2024
BUY
Open market or private purchase
$1,500 $0.3 p/Share
5,000 Added 0.33%
1,493,042 Common Stock
Sep 13 2024
BUY
Open market or private purchase
$6,200 $0.31 p/Share
20,000 Added 1.33%
1,488,042 Common Stock
Sep 11 2024
BUY
Grant, award, or other acquisition
$100,000 $0.32 p/Share
312,500 Added 17.55%
1,468,042 Common Stock
Aug 12 2024
BUY
Grant, award, or other acquisition
$98,113 $0.26 p/Share
377,358 Added 24.62%
1,155,542 Common Stock
May 06 2024
BUY
Open market or private purchase
$24,691 $0.4 p/Share
61,729 Added 7.35%
778,184 Common Stock
Mar 15 2024
BUY
Open market or private purchase
$25,000 $0.33 p/Share
75,758 Added 9.56%
716,455 Common Stock
Nov 27 2023
BUY
Open market or private purchase
$14,898 $0.44 p/Share
33,861 Added 5.02%
640,697 Common Stock
Sep 29 2023
BUY
Open market or private purchase
$9,977 $0.44 p/Share
22,676 Added 3.6%
606,836 Common Stock
Aug 25 2023
BUY
Open market or private purchase
$5,508 $0.67 p/Share
8,222 Added 1.39%
584,160 Common Stock
Aug 24 2023
BUY
Open market or private purchase
$10,045 $0.67 p/Share
14,993 Added 2.54%
575,938 Common Stock
Jul 17 2023
BUY
Open market or private purchase
$10,000 $0.59 p/Share
16,950 Added 2.93%
560,945 Common Stock
Jan 03 2023
BUY
Open market or private purchase
$50,000 $0.31 p/Share
161,291 Added 22.87%
543,995 Common Stock
Jul 18 2022
BUY
Grant, award, or other acquisition
$25,000 $0.76 p/Share
32,895 Added 7.92%
382,704 Common Stock
Apr 25 2022
BUY
Grant, award, or other acquisition
$50,000 $1.02 p/Share
49,020 Added 12.29%
349,809 Common Stock
TKE

Thomas K Equels

CEO & President
Ocala, FL

Track Institutional and Insider Activities on AIM

Follow AIM ImmunoTech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

News

Receive news related to AIM ImmunoTech Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIM